{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T11:43:50Z","timestamp":1795088630110,"version":"4.10.2"},"reference-count":149,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Bullous pemphigoid is an autoimmune blistering disease caused by autoantibodies targeting BP180 and BP230. While deposits of IgG and\/or complement along the epidermal basement membrane are typically seen suggesting complement -mediated pathogenesis, several recent lines of evidence point towards complement-independent pathways contributing to tissue damage and subepidermal blister formation. Notable pathways include macropinocytosis of IgG-BP180 complexes resulting in depletion of cellular BP180, direct induction of pro-inflammatory cytokines from keratinocytes, as well as IgE autoantibody- and eosinophil-mediated effects. We review these mechanisms which open new perspectives on novel targeted treatment modalities.<\/jats:p>","DOI":"10.3389\/fimmu.2022.912876","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T02:18:45Z","timestamp":1657160325000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":46,"title":["Insights Into the Pathogenesis of Bullous Pemphigoid: The Role of Complement-Independent Mechanisms"],"prefix":"10.3389","volume":"13","author":[{"given":"Connor","family":"Cole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keshavamurthy","family":"Vinay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Borradori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle T.","family":"Amber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1999.00546.x","article-title":"Structure and Function of Hemidesmosomes: More Than Simple Adhesion Complexes","volume":"112","author":"Borradori","year":"1999","journal-title":"J Invest Dermatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12016-017-8633-4","article-title":"Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management","volume":"54","author":"Amber","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10413.x","article-title":"Mortality of Bullous Pemphigoid in Switzerland: A Prospective Study","volume":"165","author":"Cortes","year":"2011","journal-title":"Br J Dermatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1038\/jid.2012.35","article-title":"Incidence and Mortality of Bullous Pemphigoid in France","volume":"132","author":"Joly","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17395","article-title":"European Guidelines (S3) on Diagnosis and Management of Mucous Membrane Pemphigoid, Initiated by the European Academy of Dermatology and Venereology - Part II","volume":"35","author":"Schmidt","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-018-0401-6","article-title":"Rituximab and Omalizumab for the Treatment of Bullous Pemphigoid: A Systematic Review of the Literature","volume":"20","author":"Kremer","year":"2019","journal-title":"Am J Clin Dermatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jaad.2020.01.089","article-title":"Dupilumab as a Novel Therapy for Bullous Pemphigoid: A Multicenter Case Series","volume":"83","author":"Abdat","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2022.1156","article-title":"Evaluation of Nomacopan for Treatment of Bullous Pemphigoid: A Phase 2a Nonrandomized Controlled Trial","author":"Sadik","year":"2022","journal-title":"JAMA Dermatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212233","article-title":"BP180\/Collagen XVII: A Molecular View","volume":"22","author":"Tuusa","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2011.04.019","article-title":"Dynamic Interactions of Epidermal Collagen XVII With the Extracellular Matrix: Laminin 332 as a Major Binding Partner","volume":"179","author":"Nishie","year":"2011","journal-title":"Am J Pathol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41374-018-0113-9","article-title":"The Direct Binding of Collagen XVII and Collagen IV Is Disrupted by Pemphigoid Autoantibodies","volume":"99","author":"Kamaguchi","year":"2019","journal-title":"Lab Invest"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e02-08-0548","article-title":"Interaction of the Bullous Pemphigoid Antigen 1 (BP230) and Desmoplakin With Intermediate Filaments Is Mediated by Distinct Sequences Within Their COOH Terminus","volume":"14","author":"Fontao","year":"2003","journal-title":"Mol Biol Cell"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12936","article-title":"BP180- and BP230-Specific IgG Autoantibodies in Pruritic Disorders of the Elderly: A Preclinical Stage of Bullous Pemphigoid","volume":"171","author":"Schmidt","year":"2014","journal-title":"Br J Dermatol"},{"key":"B14","first-page":"352","article-title":"The Role of Collagen XVII in Cancer: Squamous Cell Carcinoma and Beyond","volume":"10","author":"Zidan","year":"2020","journal-title":"J Anim Physiol Anim Nutr (Berl)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2008.08.009","article-title":"Subepidermal Blistering Induced by Human Autoantibodies to BP180 Requires Innate Immune Players in a Humanized Bullous Pemphigoid Mouse Model","volume":"31","author":"Liu","year":"2008","journal-title":"J Autoimmun"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.3.2015","article-title":"Autoreactive T and B Cells From Bullous Pemphigoid (BP) Patients Recognize Epitopes Clustered in Distinct Regions of BP180 and BP230","volume":"176","author":"Thoma-Uszynski","year":"2006","journal-title":"J Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/biom11101506","article-title":"A Scoping Review of the Role of Metalloproteinases in the Pathogenesis of Autoimmune Pemphigus and Pemphigoid","volume":"11","author":"Cirillo","year":"2021","journal-title":"Biomolecules"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/all.13376","article-title":"Monocytes Enhance Neutrophil-Induced Blister Formation in an Ex Vivo Model of Bullous Pemphigoid","volume":"73","author":"de Graauw","year":"2018","journal-title":"Allergy"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1172\/JCI23977","article-title":"Synergy Between a Plasminogen Cascade and MMP-9 in Autoimmune Disease","volume":"115","author":"Liu","year":"2005","journal-title":"J Clin Invest"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1084\/jem.188.3.475","article-title":"Gelatinase B-Deficient Mice Are Resistant to Experimental Bullous Pemphigoid","volume":"188","author":"Liu","year":"1998","journal-title":"J Exp Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117196","article-title":"92-kD Gelatinase Is Produced by Eosinophils at the Site of Blister Formation in Bullous Pemphigoid and Cleaves the Extracellular Domain of Recombinant 180-kD Bullous Pemphigoid Autoantigen","volume":"93","author":"Stahle-Backdahl","year":"1994","journal-title":"J Clin Invest"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117826","article-title":"The Role of Complement in Experimental Bullous Pemphigoid","volume":"95","author":"Liu","year":"1995","journal-title":"J Clin Invest"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119639","article-title":"A Major Role for Neutrophils in Experimental Bullous Pemphigoid","volume":"100","author":"Liu","year":"1997","journal-title":"J Clin Invest"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1172\/JCI3693","article-title":"A Critical Role for Neutrophil Elastase in Experimental Bullous Pemphigoid","volume":"105","author":"Liu","year":"2000","journal-title":"J Clin Invest"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI11494","article-title":"Mast Cells Play a Key Role in Neutrophil Recruitment in Experimental Bullous Pemphigoid","volume":"108","author":"Chen","year":"2001","journal-title":"J Clin Invest"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1172\/JCI17891","article-title":"Role of Different Pathways of the Complement Cascade in Experimental Bullous Pemphigoid","volume":"116","author":"Nelson","year":"2006","journal-title":"J Clin Invest"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-007-0790-5","article-title":"Experimental Models for the Autoimmune and Inflammatory Blistering Disease, Bullous Pemphigoid","volume":"299","author":"Leighty","year":"2007","journal-title":"Arch Dermatol Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1000667","article-title":"Human IgG1 Monoclonal Antibody Against Human Collagen 17 Noncollagenous 16A Domain Induces Blisters via Complement Activation in Experimental Bullous Pemphigoid Model","volume":"185","author":"Li","year":"2010","journal-title":"J Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12598113","article-title":"Complement Activation in Bullous Skin Diseases","volume":"65","author":"Jordon","year":"1975","journal-title":"J Invest Dermatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107359","article-title":"Evidence for Complement Activation via the Alternate Pathway in Skin Diseases, I. Herpes Gestationis, Systemic Lupus Erythematosus, and Bullous Pemphigoid","volume":"52","author":"Provost","year":"1973","journal-title":"J Clin Invest"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12259679","article-title":"Deposition of the Membrane Attack Complex of Complement in Bullous Pemphigoid","volume":"82","author":"Dahl","year":"1984","journal-title":"J Invest Dermatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-021-02253-8","article-title":"Characterizing the Proteome of Bullous Pemphigoid Blister Fluid Utilizing Tandem Mass Tag Labeling Coupled With LC-Ms\/MS","author":"Solimani","year":"2021","journal-title":"Arch Dermatol Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02687","article-title":"Complement-Activating Capacity of Autoantibodies Correlates With Disease Activity in Bullous Pemphigoid Patients","volume":"9","author":"Chiorean","year":"2018","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9123928","article-title":"Presence of Cutaneous Complement Deposition Distinguishes Between Immunological and Histological Features of Bullous Pemphigoid-Insights From a Retrospective Cohort Study","volume":"9","author":"Stander","year":"2020","journal-title":"J Clin Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107288","article-title":"The Complement System in Bullous Pemphigoid. I. Complement and Component Levels in Sera and Blister Fluids","volume":"52","author":"Jordon","year":"1973","journal-title":"J Clin Invest"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003402","article-title":"Antibodies to Pathogenic Epitopes on Type XVII Collagen Cause Skin Fragility in a Complement-Dependent and -Independent Manner","volume":"188","author":"Natsuga","year":"2012","journal-title":"J Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2012.11.029","article-title":"Bullous Pemphigoid IgG Induces BP180 Internalization via a Macropinocytic Pathway","volume":"182","author":"Hiroyasu","year":"2013","journal-title":"Am J Pathol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2016.108","article-title":"Macropinocytosis of Type XVII Collagen Induced by Bullous Pemphigoid IgG is Regulated via Protein Kinase C","volume":"96","author":"Iwata","year":"2016","journal-title":"Lab Invest"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1400095","article-title":"Bullous Pemphigoid Autoantibodies Directly Induce Blister Formation Without Complement Activation","volume":"193","author":"Ujiie","year":"2014","journal-title":"J Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00488","article-title":"Tissue Destruction in Bullous Pemphigoid Can Be Complement Independent and May Be Mitigated by C5ar2","volume":"9","author":"Karsten","year":"2018","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14411","article-title":"Bullous Pemphigoid Suggestive of Complement-Independent Blister Formation With Anti-BP180 IgG4 Autoantibodies","volume":"175","author":"Dainichi","year":"2016","journal-title":"Br J Dermatol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12929","article-title":"Calcitriol Exerts Anti-Inflammatory Effects in Keratinocytes Treated With Autoantibodies From a Patient With Bullous Pemphigoid","volume":"30","author":"Tukaj","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2012.01529.x","article-title":"Collagen XVII (BP180) Modulates Keratinocyte Expression of the Proinflammatory Chemokine, IL-8","volume":"21","author":"Van den Bergh","year":"2012","journal-title":"Exp Dermatol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1001753","article-title":"FcR-Independent Effects of IgE and IgG Autoantibodies in Bullous Pemphigoid","volume":"187","author":"Messingham","year":"2011","journal-title":"J Immunol"},{"key":"B45","article-title":"The IL-8 Release From Cultured Human Keratinocytes, Mediated by Antibodies to Bullous Pemphigoid Autoantigen 180, is Inhibited by Dapsone","volume":"124","author":"Schmidt","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2000.00141.x","article-title":"Autoantibodies to BP180 Associated With Bullous Pemphigoid Release Interleukin-6 and Interleukin-8 From Cultured Human Keratinocytes","volume":"115","author":"Schmidt","year":"2000","journal-title":"J Invest Dermatol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s12192-014-0513-8","article-title":"Hsp90 Blockade Modulates Bullous Pemphigoid IgG-Induced IL-8 Production by Keratinocytes","volume":"19","author":"Tukaj","year":"2014","journal-title":"Cell Stress Chaperones"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070496","article-title":"Aberrant Expression and Secretion of Heat Shock Protein 90 in Patients With Bullous Pemphigoid","volume":"8","author":"Tukaj","year":"2013","journal-title":"PloS One"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2017.07.012","article-title":"IgG4, Complement, and the Mechanisms of Blister Formation in Pemphigus and Bullous Pemphigoid","volume":"88","author":"Dainichi","year":"2017","journal-title":"J Dermatol Sci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13051","article-title":"Serum Levels of Immunoglobulins G1 and G4 Targeting the Non-Collagenous 16A Domain of BP180 Reflect Bullous Pemphigoid Activity and Predict Bad Prognosis","volume":"43","author":"Zhou","year":"2016","journal-title":"J Dermatol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2008.03361.x","article-title":"The Predominance of IgG4 in Prodromal Bullous Pemphigoid","volume":"47","author":"Lamb","year":"2008","journal-title":"Int J Dermatol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.0303-6987.2006.00458.x","article-title":"IgG4 as the Predominant IgG Subclass in Pemphigoides Gestationis","volume":"33","author":"Patton","year":"2006","journal-title":"J Cutan Pathol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0560.2002.290504.x","article-title":"A Predominant IgG4 Subclass may be Responsible for False-Negative Direct Immunofluorescence in Bullous Pemphigoid","volume":"29","author":"Buschman","year":"2002","journal-title":"J Cutan Pathol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2016.06.019","article-title":"IgG4 Autoantibodies Are Inhibitory in the Autoimmune Disease Bullous Pemphigoid","volume":"73","author":"Zuo","year":"2016","journal-title":"J Autoimmun"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14822","article-title":"Complement in Bullous Pemphigoid: Results From a Large Observational Study","volume":"176","author":"Romeijn","year":"2017","journal-title":"Br J Dermatol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1991.tb00579.x","article-title":"Bullous Pemphigoid in a Patient With a C4 Deficiency","volume":"124","author":"Shiraishi","year":"1991","journal-title":"Br J Dermatol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01752","article-title":"BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid","volume":"8","author":"Liu","year":"2017","journal-title":"Front Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2015.11.030","article-title":"Epitope-Dependent Pathogenicity of Antibodies Targeting a Major Bullous Pemphigoid Autoantigen Collagen XVII\/Bp180","volume":"136","author":"Wada","year":"2016","journal-title":"J Invest Dermatol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1994.tb03299.x","article-title":"Antibody-Binding to the 180-kD Bullous Pemphigoid Antigens at the Lateral Cell Surface Causes Their Internalization and Inhibits Their Assembly at the Basal Cell Surface in Cultured Keratinocytes","volume":"21","author":"Kitajima","year":"1994","journal-title":"J Dermatol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02028.x","article-title":"Internalization of the 180 kDa Bullous Pemphigoid Antigen as Immune Complexes in Basal Keratinocytes: An Important Early Event in Blister Formation in Bullous Pemphigoid","volume":"138","author":"Kitajima","year":"1998","journal-title":"Br J Dermatol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2008.305","article-title":"IgG From Patients With Bullous Pemphigoid Depletes Cultured Keratinocytes of the 180-kDa Bullous Pemphigoid Antigen (Type XVII Collagen) and Weakens Cell Attachment","volume":"129","author":"Iwata","year":"2009","journal-title":"J Invest Dermatol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2002.01720.x","article-title":"Autoantibodies to Bullous Pemphigoid Antigen 180 Induce Dermal-Epidermal Separation in Cryosections of Human Skin","volume":"118","author":"Sitaru","year":"2002","journal-title":"J Invest Dermatol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2010.090744","article-title":"Blockade of Autoantibody-Initiated Tissue Damage by Using Recombinant Fab Antibody Fragments Against Pathogenic Autoantigen","volume":"176","author":"Wang","year":"2010","journal-title":"Am J Pathol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12146","article-title":"Bullous Pemphigoid: Role of Complement and Mechanisms for Blister Formation Within the Lamina Lucida","volume":"22","author":"Iwata","year":"2013","journal-title":"Exp Dermatol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/00002371-200207000-00001","article-title":"Current Methods for Loading Dendritic Cells With Tumor Antigen for the Induction of Antitumor Immunity","volume":"25","author":"Zhou","year":"2002","journal-title":"J Immunother"},{"key":"B66","article-title":"Effect of IL-1beta, TNF-Alpha and IL-4 on Complement Regulatory Protein mRNA Expression in Human Articular Chondrocytes","volume":"11","author":"Hyc","year":"2003","journal-title":"Int J Mol Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.775412","article-title":"Subunit-Specific Reactivity of Autoantibodies Against Laminin-332 Reveals Direct Inflammatory Mechanisms on Keratinocytes","volume":"12","author":"Bao","year":"2021","journal-title":"Front Immunol"},{"key":"B68","article-title":"Modulation of Keratinocyte-Derived Interleukin-8 Which Is Chemotactic for Neutrophils and T Lymphocytes","volume":"139","author":"Barker","year":"1991","journal-title":"Am J Pathol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12507222","article-title":"An In Vitro Model of Immune Complex-Mediated Basement Membrane Zone Separation Caused by Pemphigoid Antibodies, Leukocytes, and Complement","volume":"78","author":"Gammon","year":"1982","journal-title":"J Invest Dermatol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4652(199705)171:2<190::AID-JCP9>3.0.CO;2-J","article-title":"Penetration of Keratinocyte-Derived Cytokines Into Basement Membrane","volume":"171","author":"Kondo","year":"1997","journal-title":"J Cell Physiol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.03.009","article-title":"Serum and Blister Fluid Levels of Cytokines and Chemokines in Pemphigus and Bullous Pemphigoid","volume":"18","author":"Kowalski","year":"2019","journal-title":"Autoimmun Rev"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)80146-0","article-title":"Elevated Levels of Interleukin-8 in Blister Fluid of Bullous Pemphigoid Compared With Suction Blisters of Healthy Control Subjects","volume":"34","author":"Schmidt","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-1811(97)00044-3","article-title":"Increased Serum Levels of Interleukin (IL)-5, IL-6 and IL-8 in Bullous Pemphigoid","volume":"16","author":"Inaoki","year":"1998","journal-title":"J Dermatol Sci"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14761","article-title":"Update on the Use of Dapsone in Dermatology","volume":"59","author":"Ghaoui","year":"2020","journal-title":"Int J Dermatol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.imlet.2007.12.017","article-title":"Innate Immunity Meets With Cellular Stress at the IKK Complex: Regulation of the IKK Complex by HSP70 and HSP90","volume":"117","author":"Salminen","year":"2008","journal-title":"Immunol Lett"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2918","article-title":"HSP90 at the Hub of Protein Homeostasis: Emerging Mechanistic Insights","volume":"11","author":"Taipale","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s12192-013-0444-9","article-title":"Do Reciprocal Interactions Between Cell Stress Proteins and Cytokines Create a New Intra-\/Extra-Cellular Signalling Nexus","volume":"18","author":"Henderson","year":"2013","journal-title":"Cell Stress Chaperones"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1721805115","article-title":"BP180 Dysfunction Triggers Spontaneous Skin Inflammation in Mice","volume":"115","author":"Zhang","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2007.00081.x","article-title":"IgG4 Autoantibodies Induce Dermal-Epidermal Separation","volume":"11","author":"Mihai","year":"2007","journal-title":"J Cell Mol Med"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1111\/all.13131","article-title":"Evidence for a Role of Eosinophils in Blister Formation in Bullous Pemphigoid","volume":"72","author":"de Graauw","year":"2017","journal-title":"Allergy"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00201","article-title":"The Role of Eosinophils in Bullous Pemphigoid: A Developing Model of Eosinophil Pathogenicity in Mucocutaneous Disease","volume":"5","author":"Amber","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(83)70036-8","article-title":"Eosinophilic Spongiosis: A Clinicopathologic Review of Seventy-One Cases","volume":"8","author":"Crotty","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1984.01650450048015","article-title":"Eosinophilic Spongiosis in Bullous Pemphigoid","volume":"120","author":"Nishioka","year":"1984","journal-title":"Arch Dermatol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(87)80227-X","article-title":"Blood Eosinophilia as a Severity Marker for Bullous Pemphigoid","volume":"16","author":"Bernard","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2016.1123092","article-title":"IgE-Mediated Mechanisms in Bullous Pemphigoid and Other Autoimmune Bullous Diseases","volume":"12","author":"van Beek","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16679","article-title":"Peripheral Eosinophilia in Bullous Pemphigoid: Prevalence and Influence on the Clinical Manifestation","volume":"179","author":"Kridin","year":"2018","journal-title":"Br J Dermatol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.17.4.2877","article-title":"Migration of Eosinophils Through Basement Membrane Components In Vitro: Role of Matrix Metalloproteinase-9","volume":"17","author":"Okada","year":"1997","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.cyto.2012.01.009","article-title":"Potent Synergistic Effect of IL-3 and TNF on Matrix Metalloproteinase 9 Generation by Human Eosinophils","volume":"58","author":"Kelly","year":"2012","journal-title":"Cytokine"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.01.078","article-title":"P38 MAP Kinase Regulates Rapid Matrix Metalloproteinase-9 Release From Eosinophils","volume":"315","author":"Wiehler","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1046\/j.0022-202x.2001.01521.x","article-title":"Respective Contribution of Neutrophil Elastase and Matrix Metalloproteinase 9 in the Degradation of BP180 (Type XVII Collagen) in Human Bullous Pemphigoid","volume":"117","author":"Verraes","year":"2001","journal-title":"J Invest Dermatol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"4833","DOI":"10.1038\/s41598-017-04687-5","article-title":"Eosinophil Cationic Protein (ECP), a Predictive Marker of Bullous Pemphigoid Severity and Outcome","volume":"7","author":"Giusti","year":"2017","journal-title":"Sci Rep"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(93)70170-X","article-title":"Granulocyte Activation in Bullous Diseases: Release of Granular Proteins in Bullous Pemphigoid and Pemphigus Vulgaris","volume":"29","author":"Czech","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1995.tb01562.x","article-title":"Serum Eosinophil Cationic Protein (ECP) in Bullous Pemphigoid","volume":"34","author":"Caproni","year":"1995","journal-title":"Int J Dermatol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1992.tb03224.x","article-title":"Eosinophil Phenotypes in Bullous Pemphigoid","volume":"19","author":"Tsuda","year":"1992","journal-title":"J Dermatol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1980.tb01683.x","article-title":"Cellular Events Leading to Blister Formation in Bullous Pemphigoid","volume":"103","author":"Dubertret","year":"1980","journal-title":"Br J Dermatol"},{"key":"B96","first-page":"897","article-title":"Deposition of Eosinophil Granule Proteins Precedes Blister Formation in Bullous Pemphigoid. Comparison With Neutrophil and Mast Cell Granule Proteins","volume":"148","author":"Borrego","year":"1996","journal-title":"Am J Pathol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/1523-1747.ep12505711","article-title":"Bullous Pemphigoid, an Ultrastructural Study of the Inflammatory Response: Eosinophil, Basophil and Mast Cell Granule Changes in Multiple Biopsies From One Patient","volume":"78","author":"Dvorak","year":"1982","journal-title":"J Invest Dermatol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13782","article-title":"Mechanisms of Pathogenic Effects of Eosinophil Cationic Protein and Eosinophil-Derived Neurotoxin on Human Keratinocytes","volume":"27","author":"Amber","year":"2018","journal-title":"Exp Dermatol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.prrv.2016.03.007","article-title":"Neutrophil Extracellular Traps in Respiratory Disease: Guided Anti-Microbial Traps or Toxic Webs","volume":"21","author":"Cortjens","year":"2017","journal-title":"Paediatr Respir Rev"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.11.002","article-title":"Eosinophil Extracellular DNA Traps in Skin Diseases","volume":"127","author":"Simon","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00701","article-title":"NET Formation in Bullous Pemphigoid Patients With Relapse Is Modulated by IL-17 and IL-23 Interplay","volume":"10","author":"Giusti","year":"2019","journal-title":"Front Immunol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202100145R","article-title":"Neutrophil Extracellular Traps Contribute to Immune Dysregulation in Bullous Pemphigoid via Inducing B-Cell Differentiation and Antibody Production","volume":"35","author":"Fang","year":"2021","journal-title":"FASEB J"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-017-2776-8","article-title":"Neutrophil Chemotaxis","volume":"371","author":"Petri","year":"2018","journal-title":"Cell Tissue Res"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15114","article-title":"Detection of IgE Autoantibodies to BP180 and BP230 and Their Relationship to Clinical Features in Bullous Pemphigoid","volume":"177","author":"Hashimoto","year":"2017","journal-title":"Br J Dermatol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.3357","article-title":"Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity","volume":"153","author":"van Beek","year":"2017","journal-title":"JAMA Dermatol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-015-1598-3","article-title":"Levels of Anti-BP180 NC16A IgE do Not Correlate With Severity of Disease in the Early Stages of Bullous Pemphigoid","volume":"307","author":"Bing","year":"2015","journal-title":"Arch Dermatol Res"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2017.07.019","article-title":"Elevated IL-31 Serum Levels in Bullous Pemphigoid Patients Correlate With Eosinophil Numbers and Are Associated With BP180-IgE","volume":"87","author":"Salz","year":"2017","journal-title":"J Dermatol Sci"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700958","article-title":"A Pathogenic Role for IgE in Autoimmunity: Bullous Pemphigoid IgE Reproduces the Early Phase of Lesion Development in Human Skin Grafted to Nu\/Nu Mice","volume":"127","author":"Fairley","year":"2007","journal-title":"J Invest Dermatol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-012615-044313","article-title":"Mechanisms of Disease: Pemphigus and Bullous Pemphigoid","volume":"11","author":"Hammers","year":"2016","journal-title":"Annu Rev Pathol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12883","article-title":"Eosinophil Localization to the Basement Membrane Zone Is Autoantibody- and Complement-Dependent in a Human Cryosection Model of Bullous Pemphigoid","volume":"25","author":"Messingham","year":"2016","journal-title":"Exp Dermatol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107725","article-title":"Human Eosinophils Express the High Affinity IgE Receptor, FcepsilonRI, in Bullous Pemphigoid","volume":"9","author":"Messingham","year":"2014","journal-title":"PloS One"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700681","article-title":"IgE Basement Membrane Zone Antibodies Induce Eosinophil Infiltration and Histological Blisters in Engrafted Human Skin on SCID Mice","volume":"127","author":"Zone","year":"2007","journal-title":"J Invest Dermatol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/j.jaci.2017.12.1002","article-title":"New Mechanism Underlying IL-31-Induced Atopic Dermatitis","volume":"141","author":"Meng","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"6639","DOI":"10.1038\/s41598-018-25094-4","article-title":"IL-31 is Crucial for Induction of Pruritus, But Not Inflammation, in Contact Hypersensitivity","volume":"8","author":"Takamori","year":"2018","journal-title":"Sci Rep"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2015.106","article-title":"IL-31 Induces Chemotaxis, Calcium Mobilization, Release of Reactive Oxygen Species, and CCL26 in Eosinophils, Which Are Capable to Release IL-31","volume":"135","author":"Kunsleben","year":"2015","journal-title":"J Invest Dermatol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2017.04.008","article-title":"Serum Levels and Tissue Expression of Interleukin-31 in Dermatitis Herpetiformis and Bullous Pemphigoid","volume":"87","author":"Bonciani","year":"2017","journal-title":"J Dermatol Sci"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2951","article-title":"Eosinophils Are a Major Source of Interleukin-31 in Bullous Pemphigoid","volume":"98","author":"Rudrich","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.11.031","article-title":"Eosinophils Mediate Tissue Injury in the Autoimmune Skin Disease Bullous Pemphigoid","volume":"138","author":"Lin","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15924","article-title":"IgE Autoreactivity in Bullous Pemphigoid: Eosinophils and Mast Cells as Major Targets of Pathogenic Immune Reactants","volume":"177","author":"Freire","year":"2017","journal-title":"Br J Dermatol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2020.04.008","article-title":"Immunoglobulin M Bullous Pemphigoid: An Enigma","volume":"6","author":"Baardman","year":"2020","journal-title":"JAAD Case Rep"},{"key":"B121","article-title":"[Disseminated Cicatricial Pemphigoid]","volume":"32","author":"Braun-Falco","year":"1981","journal-title":"Hautarzt"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.08.010","article-title":"Bullous Pemphigoid in Infancy: Clinical and Epidemiologic Characteristics","volume":"58","author":"Waisbourd-Zinman","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(88)70176-0","article-title":"Pemphigoid and Ulcerative Colitis","volume":"19","author":"Barth","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2005.tb00849.x","article-title":"Childhood Bullous Pemphigoid Successfully Treated With Diaminodiphenyl Sulfone","volume":"32","author":"Motegi","year":"2005","journal-title":"J Dermatol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14692","article-title":"Summary of Results of Serological Tests and Diagnoses for 4774 Cases of Various Autoimmune Bullous Diseases Consulted to Kurume University","volume":"175","author":"Hashimoto","year":"2016","journal-title":"Br J Dermatol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"8","DOI":"10.2340\/0001555568814","article-title":"Is There a Linear IgM Dermatosis? Significance of Linear IgM Junctional Staining in Cutaneous Immunopathology","volume":"68","author":"Velthuis","year":"1988","journal-title":"Acta Derm Venereol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(92)70027-D","article-title":"Continuous Dermoepidermal Junction IgM Detected by Direct Immunofluorescence: A Report of Nine Cases","volume":"26","author":"Helm","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.01.017","article-title":"Immunoglobulin M Pemphigoid","volume":"85","author":"Boch","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01919","article-title":"Effects of Omalizumab on FcepsilonRI and IgE Expression in Lesional Skin of Bullous Pemphigoid","volume":"10","author":"Seyed Jafari","year":"2019","journal-title":"Front Immunol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02331","article-title":"The Intersection of IgE Autoantibodies and Eosinophilia in the Pathogenesis of Bullous Pemphigoid","volume":"10","author":"Messingham","year":"2019","journal-title":"Front Immunol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.143.2.249","article-title":"The Role of IgE Anti-Basement Membrane Zone Autoantibodies in Bullous Pemphigoid","volume":"143","author":"Woodley","year":"2007","journal-title":"Arch Dermatol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1128\/cdli.2.3.297-301.1995","article-title":"Connective Tissue Mast Cells Exhibit Time-Dependent Degranulation Heterogeneity","volume":"2","author":"Kaminer","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.23736\/S0031-0808.20.03997-X","article-title":"Eosinophils in Bullous Pemphigoid","volume":"63","author":"Jones","year":"2021","journal-title":"Panminerva Med"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-014-8547-7","article-title":"Unraveling the Significance of IgE Autoantibodies in Organ-Specific Autoimmunity: Lessons Learned From Bullous Pemphigoid","volume":"59","author":"Messingham","year":"2014","journal-title":"Immunol Res"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.11.035","article-title":"Pathogenicity of IgE in Autoimmunity: Successful Treatment of Bullous Pemphigoid With Omalizumab","volume":"123","author":"Fairley","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10748.x","article-title":"Successful Management of Severe Infant Bullous Pemphigoid With Omalizumab","volume":"166","author":"Dufour","year":"2012","journal-title":"Br J Dermatol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2012.1604","article-title":"Successful Treatment of Bullous Pemphigoid With Omalizumab","volume":"148","author":"London","year":"2012","journal-title":"Arch Dermatol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13758","article-title":"Successful Treatment of Bullous Pemphigoid With Omalizumab as Corticosteroid-Sparing Agent: Report of Two Cases and Review of Literature","volume":"30","author":"Balakirski","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1021\/bi00033a020","article-title":"Characterization of Complex Formation by Humanized Anti-IgE Monoclonal Antibody and Monoclonal Human IgE","volume":"34","author":"Liu","year":"1995","journal-title":"Biochemistry"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.06.032","article-title":"Omalizumab-Induced Reductions in Mast Cell Fce Psilon RI Expression and Function","volume":"114","author":"Beck","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2010.07.011","article-title":"Omalizumab-Induced Decrease of FcxiRI Expression in Patients With Severe Allergic Asthma","volume":"104","author":"Chanez","year":"2010","journal-title":"Respir Med"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15816","article-title":"From Bench to Bedside: Evolving Therapeutic Targets in Autoimmune Blistering Disease","volume":"33","author":"Kridin","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.738907","article-title":"Efficacy and Safety of Dupilumab in Moderate-To-Severe Bullous Pemphigoid","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.611549","article-title":"Case Report: Combination of Omalizumab and Dupilumab for Recalcitrant Bullous Pemphigoid","volume":"11","author":"Seyed Jafari","year":"2020","journal-title":"Front Immunol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.2526","article-title":"Dupilumab for the Treatment of Recalcitrant Bullous Pemphigoid","volume":"154","author":"Kaye","year":"2018","journal-title":"JAMA Dermatol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1111\/all.13950","article-title":"Mepolizumab Failed to Affect Bullous Pemphigoid: A Randomized, Placebo-Controlled, Double-Blind Phase 2 Pilot Study","volume":"75","author":"Simon","year":"2020","journal-title":"Allergy"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1080\/25785826.2019.1619233","article-title":"Dipeptidyl Peptidase IV Inhibitor-Associated Bullous Pemphigoid: A Recently Recognized Autoimmune Blistering Disease With Unique Clinical, Immunological and Genetic Characteristics","volume":"42","author":"Nishie","year":"2019","journal-title":"Immunol Med"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2008.412","article-title":"A Comparison of Two Regimens of Topical Corticosteroids in the Treatment of Patients With Bullous Pemphigoid: A Multicenter Randomized Study","volume":"129","author":"Joly","year":"2009","journal-title":"J Invest Dermatol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011592","article-title":"A Comparison of Oral and Topical Corticosteroids in Patients With Bullous Pemphigoid","volume":"346","author":"Joly","year":"2002","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.912876\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T02:18:54Z","timestamp":1657160334000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.912876\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,7]]},"references-count":149,"alternative-id":["10.3389\/fimmu.2022.912876"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.912876","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,7]]},"article-number":"912876"}}